TP53 and hepatocellular carcinoma: Interestingly, a prior study demonstrated a positive correlation between AIG1 expression levels and the survival of hepatocellular carcinoma patients 32, seeming to indicate a potential contradiction between AIG1 upregulation and the Pirh2/p53 axis in cancer contexts.